MPR10h
FDA Drug Approval Decisions Expected in May 2025
The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
Supreme Court backs FDA’s denials of flavored vaping products for now
The Supreme Court on Wednesday backed a series of decisions by the US Food and Drug Administration to deny market access for ...
Unanimous Supreme Court upholds FDA block of flavored vapes
The Supreme Court backed the FDA's refusal to authorize the sale of kid-friendly flavored vapes, including the flavors ...
Healthline18h
FDA Authorizes First At-Home Test for Chlamydia, Gonorrhea: What to Know
The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...
Exclusive: FDA staff struggle to meet product review deadlines after DOGE layoffs
Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...
FDA layoffs could raise drug costs and erode food safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...
Supreme Court rules in favor of FDA in dispute over flavored vapes
A unanimous Supreme Court on Wednesday overturned a lower court ruling and found the Food and Drug Administration acted ...
US Supreme Court largely backs FDA's denial of flavored vape product applications
The U.S. Supreme Court on Wednesday largely backed the U.S. Food and Drug Administration's refusal to let two e-cigarette ...
Stockhead on MSN23h
Level achieved: Orthocell gains FDA approval for flagship nerve repair product
Orthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial ...
MPR1d
Vanrafia Gets Accelerated Approval for Immunoglobulin A Nephropathy
The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...
T-Cell Acute Lymphoblastic Leukemia Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...
Supreme Court rules for the FDA in flavored vapes dispute
The Food and Drug Administration has been reluctant to approve flavored e-cigarettes over public health concerns.